Kseniia Boriachek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kseniia Boriachek has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alfred King-Yin Lam
School of Medicine and Dentistry, Griffith University, Gold Coast, Australia
2 shared publications - Muhammad Johirul Alam Shiddiky
Rural Health Research Institute (RHRI), Charles Sturt University, Orange, NSW 2800, Australia
2 shared publications - Nam-Trung Nguyen
Griffith University
2 shared publications - Nazmul Islam
School of Natural Sciences, Griffith University, Nathan Campus, QLD 4111, Australia
2 shared publications - Vinod Gopalan
School of Medicine & Dentistry, Griffith University, Gold Coast, Australia
2 shared publications - Muhammad Umer
Queensland Micro- and Nanotechnology Centre (QMNC), Griffith University, Nathan, QLD, 4111, Australia
1 shared publication
Latest Publications
- 12 February 2018
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 143 (7) , 1662-1669
An amplification-free electrochemical detection of exosomal miRNA-21 in serum samples
Recent evidence suggests that small non-coding RNAs such as microRNA (miRNA) encapsulated in exosomes represent an important mechanism of communication between the cells. Exosomal miRNAs play an important role in carcinogenesis via enhancing the cell to cell communication and targeting the cell growth molecular pathways which in turn facilitate metastasis in cancers. Despite progressive advances, the current methods for the exosomal miRNA detection mostly rely on labor-intensive sequencing approaches which are often prone to amplification bias and require costly and bulky equipment. Herein, we report an electrochemical approach for the detection of cancer-derived exosomal miRNAs in human serum samples by selectively isolating the target miRNA using magnetic beads pre-functionalized with capture probes and then directly adsorbing the targets onto a gold electrode surface. The level of adsorbed miRNA is detected electrochemically in the presence of an [Fe(CN)6]4−/3− redox system. This method enabled an excellent detection sensitivity of 1.0 pM with a relative standard deviation (%RSD) of n = 8) collected from patients with colorectal adenocarcinoma (CRC). We believe that our approach could be useful in clinical settings for the quantification of exosomal miRNA in cancer patients.
- 12 February 2018
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 143 (7) , 1662-1669
An amplification-free electrochemical detection of exosomal miRNA-21 in serum samples
Recent evidence suggests that small non-coding RNAs such as microRNA (miRNA) encapsulated in exosomes represent an important mechanism of communication between the cells. Exosomal miRNAs play an important role in carcinogenesis via enhancing the cell to cell communication and targeting the cell growth molecular pathways which in turn facilitate metastasis in cancers. Despite progressive advances, the current methods for the exosomal miRNA detection mostly rely on labor-intensive sequencing approaches which are often prone to amplification bias and require costly and bulky equipment. Herein, we report an electrochemical approach for the detection of cancer-derived exosomal miRNAs in human serum samples by selectively isolating the target miRNA using magnetic beads pre-functionalized with capture probes and then directly adsorbing the targets onto a gold electrode surface. The level of adsorbed miRNA is detected electrochemically in the presence of an [Fe(CN)6]4−/3− redox system. This method enabled an excellent detection sensitivity of 1.0 pM with a relative standard deviation (%RSD) of n = 8) collected from patients with colorectal adenocarcinoma (CRC). We believe that our approach could be useful in clinical settings for the quantification of exosomal miRNA in cancer patients.
- 4 May 2017
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 142 (12) , 2211-2219
Quantum dot-based sensitive detection of disease specific exosome in serum
Tumor-derived exosomes have emerged as promising cancer biomarkers due to their unique composition and functions. Herein, we report a stripping voltammetric immunoassay for the electrochemical detection of disease-specific exosomes using quantum dots as signal amplifiers. The assay involves three subsequent steps where bulk exosome populations are initially magnetically captured on magnetic beads by a generic tetraspanin antibody (e.g., CD9 or CD63) followed by the identification of disease-specific exosomes using cancer-related. Here, we used CdSe quantum dot (CdSeQD) functionalised-biotinylated HER-2 and FAM134B antibodies as breast and colon cancer markers. After magnetic washing and purification steps, acid dissolution of CdSeQDs and subsequent anodic stripping voltammetric quantification of Cd2+ were carried out at the bare glassy carbon working electrode. This method enabled sensitive detection of 100 exosomes per μL with a relative standard deviation (%RSD) of n = 9) collected from patients with colorectal adenocarcinoma. We believe that our approach could potentially represent an effective bioassay for the quantification of disease-specific exosomes in clinical samples.
- 4 May 2017
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 142 (12) , 2211-2219
Quantum dot-based sensitive detection of disease specific exosome in serum
Tumor-derived exosomes have emerged as promising cancer biomarkers due to their unique composition and functions. Herein, we report a stripping voltammetric immunoassay for the electrochemical detection of disease-specific exosomes using quantum dots as signal amplifiers. The assay involves three subsequent steps where bulk exosome populations are initially magnetically captured on magnetic beads by a generic tetraspanin antibody (e.g., CD9 or CD63) followed by the identification of disease-specific exosomes using cancer-related. Here, we used CdSe quantum dot (CdSeQD) functionalised-biotinylated HER-2 and FAM134B antibodies as breast and colon cancer markers. After magnetic washing and purification steps, acid dissolution of CdSeQDs and subsequent anodic stripping voltammetric quantification of Cd2+ were carried out at the bare glassy carbon working electrode. This method enabled sensitive detection of 100 exosomes per μL with a relative standard deviation (%RSD) of n = 9) collected from patients with colorectal adenocarcinoma. We believe that our approach could potentially represent an effective bioassay for the quantification of disease-specific exosomes in clinical samples.